title: Corynebacterium jeikeium sepsis after 8-methoxypsolaren photopheresis for cutaneous T-cell lymphoma.
abstract: We describe a patient with cutaneous T-cell lymphoma who developed Corynebacterium jeikeium sepsis after experimental treatment with 8-methoxypsolaren. The epidemiology and clinical features of C. jeikeium infection are discussed. The patient was successfully treated with intravenous vancomycin without recurrence.
authors.affiliation: Division of Infectious Diseases, Department of Medicine, UCLA Medical Center, Los Angeles, CA, USA. oumeh@mednet.ucla.edu
authors.forename: Obiamiwe Chukwudiebere
authors.initials: OC
authors.lastname: Umeh
authors.forename: Bernard Michael
authors.initials: BM
authors.lastname: Kubak
authors.forename: David Alexander
authors.initials: DA
authors.lastname: Pegues
authors.forename: Matthew Richard
authors.initials: MR
authors.lastname: Leibowitz
authors.forename: Larry
authors.initials: L
authors.lastname: Froch
mesh_terms: D000368:Aged; D016470:Bacteremia / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology; D003352:Corynebacterium / Q000145:classification; D003354:Corynebacterium Infections / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology; D005500:Follow-Up Studies; D006801:Humans; D016867:Immunocompromised Host; D007262:Infusions, Intravenous; D016410:Lymphoma, T-Cell, Cutaneous / Q000276:immunology* / Q000628:therapy; D008297:Male; D008730:Methoxsalen / Q000627:therapeutic use; D009894:Opportunistic Infections / Q000188:drug therapy / Q000276:immunology / Q000382:microbiology*; D017893:Photopheresis / Q000379:methods*; D018570:Risk Assessment; D012720:Severity of Illness Index; D016896:Treatment Outcome; D014640:Vancomycin / Q000008:administration & dosage
chemical_list: D014640:Vancomycin; D008730:Methoxsalen